« E-LUMINEXX Vascular Stent The E-LUMINEXX Vascular Stent is a thin, | Main | FDA Issues Guidances for Industry to Improve the Safety of »

Schering cutting staff, but has potential blockbuster, other promising drugs


Schering cutting staff, but has potential blockbuster, other promising drugs on horizon (Canadian Business)
Schering-Plough Corp., a major maker of prescription drugs and consumer and animal health products, reports earnings for the fourth quarter
 

©2006 FDA-News.com. All rights reserved.